ASCO® Gastrointestinal Cancers Symposium 2023


Tucatinib | Colorectal Cancer | Abstract #198

HER2 testing in colorectal cancer: Concordance analysis between breast and gastric scoring algorithms from the MOUNTAINEER trial

Tucatinib | Colorectal Cancer | Abstract #TPS261

MOUNTAINEER-03: Phase 3 study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer (trial in progress)

Colorectal Cancer | Abstract #53

Burden of Illness in Metastatic Colorectal Cancer

SEA-CD40 | Pancreatic Ductal Adenocarcinoma | Abstract #708

Updated Results of a Phase 1 Study of SEA-CD40, Gemcitabine, Nab-Paclitaxel, and Pembrolizumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) (SGNS40-001)